Back
Sangamo Therapeutics Quote, Financials, Valuation and Earnings
Buy
53
SGMO
Sangamo Therapeutics
Last Price:
0.64
Seasonality Move:
9.53%
7 Day Trial
ALL ACCESS PASS
$
7
Sangamo Therapeutics Price Quote
$0.64
-0.01 (5.14%)
(Updated: May 18, 2024 at 5:53 AM ET)
Sangamo Therapeutics Key Stats
Buy
53
Sangamo Therapeutics (SGMO)
is a Buy
Day range:
$0.60 - $0.70
52-week range:
$0.29 - $1.67
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.14
P/B ratio:
2.38%
Volume:
4.9M
Avg. volume:
1.8M
1-year change:
-51.88%
Market cap:
$134.8M
Revenue:
$176.2M
EPS:
$-1.86
How Much Does Sangamo Therapeutics Make?
-
How Much Are Sangamo Therapeutics's Sales Annually?
SGMO Revenues are $176.2M -
How Much Profit Does Sangamo Therapeutics's Make A Year?
SGMO net income is -$257.8M
Is Sangamo Therapeutics Growing As A Company?
-
What Is Sangamo Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -1% -
What Is Sangamo Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Sangamo Therapeutics Stock Price Performance
-
Did Sangamo Therapeutics Stock Go Up Last Month?
Sangamo Therapeutics share price went up by 25.89% last month -
Did SGMO's Share Price Rise Over The Last Year?
SGMO share price fell by -51.88% over the past 1 year
What Is Sangamo Therapeutics 52-Week High & Low?
-
What Is Sangamo Therapeutics’s 52-Week High Share Price?
Sangamo Therapeutics has traded as high as $1.67 over the past 52 weeks -
What Is Sangamo Therapeutics’s 52-Week Low Share Price?
Sangamo Therapeutics has traded as low as $0.29 over the past 52 weeks
Sangamo Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Sangamo Therapeutics?
-
How Much Debt Does Sangamo Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Sangamo Therapeutics Have?
Cash and short term investments quarterly total is $54.4M -
What Is Sangamo Therapeutics’s Book Value Per Share?
Book value per share is 0.28
Is Sangamo Therapeutics Cash Flow Positive?
-
What Is SGMO Cash Flow From Operations?
Cash flow from operations (TTM) is -$207.2M -
What Is Sangamo Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $28.7M -
What Is Sangamo Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $153.6M
Sangamo Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
SGMO return on invested capital is -194.4% -
What Is Sangamo Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -128.18% -
What Is SGMO Return On Equity?
ROE is a measure of profitability and is -194.4%
Sangamo Therapeutics Earnings Date & Stock Price
-
What Is Sangamo Therapeutics's Stock Price Today?
A single share of SGMO can be purchased today for 0.65 -
What Is Sangamo Therapeutics’s Stock Symbol?
Sangamo Therapeutics trades on the nasdaq under the ticker symbol: SGMO -
When Is Sangamo Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Sangamo Therapeutics is scheduled on August 9, 2024 -
When Is SGMO's next ex-dividend date?
Sangamo Therapeutics's next ex-dividend date is May 19, 2024 -
How To Buy Sangamo Therapeutics Stock?
You can buy Sangamo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Sangamo Therapeutics Competitors
-
Who Are Sangamo Therapeutics's Competitors?
Below is a list of companies who compete with Sangamo Therapeutics or are related in some way:
Sangamo Therapeutics Dividend Yield
Data Unavailable
Sangamo Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -1.26% |
| Revenue: | -99.7% | 0% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 4.00 |
| Upside from Last Price: | 515.76% |